- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2014–2023 · cooperative agreement · UM1
Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site) - Incorporation of Mayo Clinic Cancer Center as an Affiliated Center
Keith T Flaherty · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · research · R01
A novel flat-panel detector for advanced on-board radiation therapy imaging
Ross I. Berbeco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · research · R01
A novel flat-panel detector for advanced on-board radiation therapy imaging
Ross I. Berbeco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · research · R01
A novel flat-panel detector for advanced on-board radiation therapy imaging
Ross I. Berbeco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2024 · cooperative agreement · U01
Anatomic and functional characterization of the intestinal crypt-villus niche
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2026 · research · R01
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · grant · DP1
Engineering epigenetic therapy for sickle cell disease
Carl D Novina · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2024 · cooperative agreement · U01
Anatomic and functional characterization of the intestinal crypt-villus niche
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2024 · cooperative agreement · U01
Anatomic and functional characterization of the intestinal crypt-villus niche
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · cooperative agreement · UM1
Dana-Farber/Harvard Cancer Center ET-CTN with Phase I Emphasis
Keith T Flaherty · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · research · R01
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
Ross I. Berbeco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2023 · cooperative agreement · UM1
Dana‐Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)
Keith T Flaherty · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2024 · cooperative agreement · U01
Anatomic and functional characterization of the intestinal crypt-villus niche
Ramesh A Shivdasani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · research · R01
Functional and biologic significance of deacetylase3 inhibition in myeloma
Kenneth C. Anderson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2026 · cooperative agreement · U10
ECOG-ACRIN Network Group Statistics and Data Management Center
Constantine A. Gatsonis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · research · R01
Mechanism and function of autosomal analog of X inactivation
Alexander Gimelbrant · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · cooperative agreement · U10
ECOG-ACRIN Network Group Statistics and Data Management Center
Constantine A. Gatsonis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · research · R25
Workshop on Methods in Supportive Oncology Research
William F Pirl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · research · R01
Stroma-mediated clonal evolution in Multiple Myeloma
Irene M. Ghobrial · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · research · R01
A novel flat-panel detector for advanced on-board radiation therapy imaging
Ross I. Berbeco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · research · R01
Metabolic and epigenetic dependencies in melanomas during metastasis and targeted-drug resistance
Pere Puigserver · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · research · R01
A novel flat-panel detector for advanced on-board radiation therapy imaging
Ross I. Berbeco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · cooperative agreement · UM1
Dana-Farber/Harvard Cancer Center ET-CTN with Phase I Emphasis
Keith T Flaherty · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2026 · cooperative agreement · UM1
Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)
Keith T Flaherty · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2024 · research · R25
Workshop on Methods in Supportive Oncology Research
William F Pirl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · cooperative agreement · UM1
Dana-Farber/Harvard Cancer Center ET-CTN with Phase I Emphasis
Keith T Flaherty · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2020 · research · SU2C–FARRAH FAWCETT FOUNDATION HPV RESEARCH TEAM
Therapeutic CD8 Vaccines Against Conserved E7 HPV Epitopes Identified by MS
Ellis L. Reinherz · Dana-Farber Cancer Institute · funded by Stand Up To Cancer
2014–2027 · cooperative agreement · UM1
Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site)
Keith T Flaherty · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2026 · cooperative agreement · U10
ECOG-ACRIN Network Group Statistics and Data Management Center
Constantine A. Gatsonis · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2027 · cooperative agreement · UM1
DF/HCC Preclinical Translation-Focused Clinical Investigator to Bridge PDXNet and the ETCTN
Keith T Flaherty · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2030 · research · R25
Workshop on Research Methods in Supportive Oncology
William F Pirl · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · cooperative agreement · U10
Administrative Core
Robert J Gray · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · cooperative agreement · U10
Data Management Core
Jean Macdonald · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2026 · cooperative agreement · U10
Data Management Core
Jean Macdonald · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2026 · cooperative agreement · U10
Statistics Core
Robert J Gray · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2026 · cooperative agreement · U10
Administrative Core
Robert J Gray · Dana-Farber Cancer Institute · funded by National Institutes of Health
2014–2025 · cooperative agreement · U10
Statistics Core
Robert J Gray · Dana-Farber Cancer Institute · funded by National Institutes of Health
2013–2024 · program · P50
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
Eric P Winer · Dana-Farber Cancer Institute · funded by National Institutes of Health
2013–2020 · research · R01
Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma
Steven Dubois · Dana-Farber Cancer Institute · funded by National Institutes of Health
2013–2022 · cooperative agreement · U01
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
William C. Hahn · Dana-Farber Cancer Institute · funded by National Institutes of Health
